Stock listing

APGE Stock Price, News, Filings & Events — Apogee Therapeutics, Inc.

Selected listing: APGE · NASDAQ · USD · US

This page tracks Apogee Therapeutics, Inc.'s APGE:NASDAQ listing on NASDAQ in USD for US, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following APGE:NASDAQ. APGE:NASDAQ is the stock-level entry point for investors researching Apogee Therapeutics, Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Apogee Therapeutics, Inc. (ticker: APGE) is a publicly traded company based in the United States, with a market capitalization of approximately $10.1 billion. The company focuses on developing innovative therapeutic solutions. Apogee is committed to advancing healthcare through its research and development efforts.

APGE:NASDAQUSDUSUpdated August 28, 2026
Apogee Therapeutics, Inc. logo
Ticker
APGE:NASDAQ
Asset type
Stock
Market cap
$10.22B
Sector
Health Technology
Industry
Biotechnology
Exchange
NASDAQ
Currency
USD

Apogee Therapeutics, Inc. APGE:NASDAQ stock context

This page tracks Apogee Therapeutics, Inc.'s APGE:NASDAQ listing on NASDAQ in USD for US, including stock price context, company news, filings, investor events, AI research briefs, and market updates for investors following APGE:NASDAQ. APGE:NASDAQ is the stock-level entry point for investors researching Apogee Therapeutics, Inc., while company-level investor report content can remain shared across the same issuer's public listings. 6ix connects this selected listing to available company updates, filings, investor events, replay content, and AI research briefs so stock search leads to the relevant company context without making another exchange listing primary. Apogee Therapeutics, Inc. (ticker: APGE) is a publicly traded company based in the United States, with a market capitalization of approximately $10.1 billion. The company focuses on developing innovative therapeutic solutions. Apogee is committed to advancing healthcare through its research and development efforts.

Latest news from Apogee Therapeutics, Inc.

All Apogee Therapeutics, Inc. news →

Apogee Therapeutics, Inc. earnings calls

Research Apogee Therapeutics, Inc.

Alternate listings